Chlamydia pneumoniae: How to Document Respiratory Infection
As Chlamydia pneumoniae is an obligate intracellular parasite capable of causing prolonged, often subclinical infection, diagnosis of C. pneumoniae infection is somewhat complicated. Although isolation of the organism implies infection, it may not imply that the organism is causing pneumonia or other respiratory infection in the patient. It is also unclear whether colonization or asymptomatic infection without disease elicits an antibody response. Multiple diagnostic methods have been evaluated, but there is no “gold standard” for determining whether disease occurring in an individual is due to C. pneumoniae. Although it has been suggested that there are differences in the antibody response to primary infection, reinfection and reactivated infection, there are limited data correlating serology with culture. This is further complicated by the lack of standardized methods for serology and nonculture methods such as polymerase chain reaction (PCR).
KeywordsAcute Otitis Medium Antimicrob Agent Chlamydia Trachomatis Major Outer Membrane Protein Obligate Intracellular Parasite
Unable to display preview. Download preview PDF.
- 14.Hammerschlag MR, Gregory W, Schwartz DB, Pistorious BJ, Inverso JA, Kolokathis A (1997) Azithromycin in the treatment of community-acquired pneumonia (CAP) due to Chlamydia pneumoniae. In: Abstracts of the 37th Interscience Conference on Antimicrobial Agents and Chemotherapy, September 28–October 1, 1997. American Society for Microbiology, Washington, DC, abstr K-138, p 352Google Scholar
- 22.Hyman CL, Roblin PM, Gaydos CA, Quinn TC, Schachter J, Hammerschlag MR (1995) The prevalence of asymptomatic nasopharyngeal carriage of Chlamydia pneumoniaein subjectively healthy adults: assessment by polymerase chain reaction-enzyme immunoassay and culture. Clin Infect Dis 20: 1174–1178PubMedCrossRefGoogle Scholar
- 26.Moss TR, Darougar S, Woodland RM et al (1993) Antibodies to Chlamydia species in patients attending a genitourinary clinic and the impact of antibodies to C. pneumoniae and C. psittaci on the sensitivity and the specificity of C. trachomatis serology tests. Sex Transm Dis 20: 61–65PubMedCrossRefGoogle Scholar
- 27.Peeling RW, Wang SP, Grayston JT, Blasi F, Boman J, Clad A, Freidank H, Gaydos CA, Gnarpe J, Hagiwara T, Jones RB, Orfila J, Persson K, Poulakkainen M, Saikku P, Schachter J (1998) Chlamydia serology: inter-laboratory variation in microimmunofluorescence results. In: Stephens RS, Byrne GI, Christiansen G, Clarke IN, Grayston JT, Rank RG, Ridgway GL, Saikku P, Schachter J, Stamm WE (eds) Chlamydia infections. Proceedings of the 9th International Symposium on Human Chlamydia Infections, 21–28 June, 1998. University of California, San Francisco, pp 159–162Google Scholar
- 30.Dean D, Roblin P, Mandel L, Schachter J, Hammerschlag MR (1998) Molecular evaluation of serial isolates from patients with persistent Chlamydia pneumoniae infections. In: Stephens RS, Byrne GI, Christiansen G, Clarke IN, Grayston JT, Rank RG, Ridgway GL, Saikku P, Schachter J, Stamm WE (eds) Chlamydia infections. In: Proceedings of the 9th International Symposium on Human Chlamydial Infections, 21–28 June, 1998. University of California, San Francisco, pp 219–222Google Scholar
- 33.File TM, Segreti J, Dunbar L, Player R, Kohler R, Williams RR, Kojak C, Rubin A (1997) A multicenter, randomized study comparing the efficacy and safety of intravenous and/or oral levofloxacin versus ceftriaxone and/or cefuroxime axetil in the treatment of adults with community-acquired pneumonia. Antimicrob Agents Chemother 41: 1965–1972PubMedGoogle Scholar